Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1993 Apr 1;148(7):1173–1177.

Clinical and epidemiologic characteristics of hepatitis C in a gastroenterology/hepatology practice in Ottawa.

L J Scully 1, S Mitchell 1, P Gill 1
PMCID: PMC1490869  PMID: 8457958

Abstract

OBJECTIVE: To examine the clinical and epidemiologic features of hepatitis C virus (HCV) infection in a gastroenterology/hepatology practice in Ottawa. DESIGN: Retrospective chart review. PATIENTS: Sixty-three consecutive patients found to be anti-HCV positive. Their charts were analysed with respect to risk factors, history of hepatitis, serum aspartate aminotransferase (AST) levels and the presence of hepatitis B markers. The long-term sexual partners of 29 patients agreed to undergo HCV antibody testing. RESULTS: Of the patients 48 (76%) had been exposed to HCV parenterally: 27 used intravenous drugs, and 21 had received blood or blood products. Eleven patients did not have any known risk factor (sporadic infection), but eight of them had lived in countries where hepatitis C may be more prevalent; the other three had locally acquired infection. The mean serum AST level at the first visit was 140 (normally less than 40) IU/L. At least one hepatitis B marker was identified in 33% of the patients. None of the sexual partners who were tested were anti-HCV positive. CONCLUSION: Most cases of hepatitis C in Ottawa are acquired through parenteral exposure; sexual transmission is rare. Sporadic infection in the Ottawa region is rare but may be more common in people from countries with a higher prevalence rate of hepatitis C. Most cases of hepatitis C are asymptomatic.

Full text

PDF
1173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q. L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989 Nov 30;321(22):1494–1500. doi: 10.1056/NEJM198911303212202. [DOI] [PubMed] [Google Scholar]
  2. Alter M. J., Hadler S. C., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Moyer L. A., Fields H. A., Bradley D. W. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA. 1990 Nov 7;264(17):2231–2235. [PubMed] [Google Scholar]
  3. Bahakim H., Bakir T. M., Arif M., Ramia S. Hepatitis C virus antibodies in high-risk Saudi groups. Vox Sang. 1991;60(3):162–164. doi: 10.1111/j.1423-0410.1991.tb00894.x. [DOI] [PubMed] [Google Scholar]
  4. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  5. Ebeling F., Naukkarinen R., Leikola J. Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity. Lancet. 1990 Apr 21;335(8695):982–983. doi: 10.1016/0140-6736(90)91055-f. [DOI] [PubMed] [Google Scholar]
  6. Esteban J. I., Esteban R., Viladomiu L., López-Talavera J. C., González A., Hernández J. M., Roget M., Vargas V., Genescà J., Buti M. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 1989 Aug 5;2(8658):294–297. doi: 10.1016/s0140-6736(89)90485-6. [DOI] [PubMed] [Google Scholar]
  7. Esteban J. I., González A., Hernández J. M., Viladomiu L., Sánchez C., López-Talavera J. C., Lucea D., Martin-Vega C., Vidal X., Esteban R. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med. 1990 Oct 18;323(16):1107–1112. doi: 10.1056/NEJM199010183231605. [DOI] [PubMed] [Google Scholar]
  8. Everhart J. E., Di Bisceglie A. M., Murray L. M., Alter H. J., Melpolder J. J., Kuo G., Hoofnagle J. H. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med. 1990 Apr 1;112(7):544–545. doi: 10.7326/0003-4819-112-7-544. [DOI] [PubMed] [Google Scholar]
  9. Fried M. W., Shindo M., Fong T. L., Fox P. C., Hoofnagle J. H., Di Bisceglie A. M. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology. 1992 Apr;102(4 Pt 1):1306–1308. [PubMed] [Google Scholar]
  10. Giulivi A., Aye M. T., Gray E., Scalia V., Gill P., Cheng G. Anti-hepatitis C virus (HCV) screening at a Canadian Red Cross center: significance of a positive c100 HCV enzyme-linked immunosorbent assay. Transfusion. 1992 May;32(4):309–311. doi: 10.1046/j.1537-2995.1992.32492263442.x. [DOI] [PubMed] [Google Scholar]
  11. Janot C., Couroucé A. M., Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet. 1989 Sep 30;2(8666):796–797. doi: 10.1016/s0140-6736(89)90851-9. [DOI] [PubMed] [Google Scholar]
  12. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  13. Meyer R. A., Gordon S. C. Epidemiology of hepatitis C virus infection in a suburban Detroit community. Am J Gastroenterol. 1991 Sep;86(9):1224–1226. [PubMed] [Google Scholar]
  14. Richards C., Holland P., Kuramoto K., Douville C., Randell R. Prevalence of antibody to hepatitis C virus in a blood donor population. Transfusion. 1991 Feb;31(2):109–113. doi: 10.1046/j.1537-2995.1991.31291142939.x. [DOI] [PubMed] [Google Scholar]
  15. Schulman S., Grillner L. Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partners. Scand J Infect Dis. 1990;22(4):393–397. doi: 10.3109/00365549009027068. [DOI] [PubMed] [Google Scholar]
  16. Sirchia G., Bellobuono A., Giovanetti A., Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet. 1989 Sep 30;2(8666):797–797. doi: 10.1016/s0140-6736(89)90852-0. [DOI] [PubMed] [Google Scholar]
  17. Tajima K., Shimotohno K., Oki S. Natural horizontal transmission of HCV in microepidemic town in Japan. Lancet. 1991 Jun 8;337(8754):1410–1411. doi: 10.1016/0140-6736(91)93089-r. [DOI] [PubMed] [Google Scholar]
  18. Watanabe J., Minegishi K., Mitsumori T., Ishifuji M., Oguchi T., Ueda M., Tokunaga E., Tanaka E., Kiyosawa K., Furuta S. Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang. 1990;59(2):86–88. doi: 10.1111/j.1423-0410.1990.tb05015.x. [DOI] [PubMed] [Google Scholar]
  19. Weiner A. J., Kuo G., Bradley D. W., Bonino F., Saracco G., Lee C., Rosenblatt J., Choo Q. L., Houghton M. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet. 1990 Jan 6;335(8680):1–3. doi: 10.1016/0140-6736(90)90134-q. [DOI] [PubMed] [Google Scholar]
  20. Wejstål R., Hermodsson S., Iwarson S., Norkrans G. Mother to infant transmission of hepatitis C virus infection. J Med Virol. 1990 Mar;30(3):178–180. doi: 10.1002/jmv.1890300306. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES